FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention relates to chemical-pharmaceutical industry. Pharmaceutical compositions including, at least, one compound of formula where -X- represents, for instance, group of formula and Y represents, for instance, group of formula or its pharmaceutically acceptable salts, esters or amides, or pro-drugs and pharmaceutically acceptable carrier, which is acceptable in therapy, can be applied for modulation in vitro and in vivo processes of binding, mediated by binding of E-, P- or L- selectin.
EFFECT: obtaining novel floroglucin derivatives.
9 cl, 10 ex, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
NOVEL POLYCYCLIC COMPOUNDS | 2006 |
|
RU2434006C2 |
NOVEL NITROCATECOL DERIVATIVES POSSESSING ACTIVITY AS SELECTIN LIGANDS | 2006 |
|
RU2428979C2 |
SMALL DI- AND TRIVALENT MOLECULES OF SELECTIN INHIBITORS, PHARMACEUTICAL COMPOSITION, METHOD OF SELECTING INHIBITION | 1996 |
|
RU2165931C2 |
METHOD FOR TREATMENT OF ALLERGY BY USING SUBSTITUTED PYRAZOLES | 2001 |
|
RU2259202C2 |
BENZYLAMINE DERIVATIVES | 2014 |
|
RU2660421C2 |
BENZYLAMINE DERIVATIVES AS INHIBITORS OF PLASMA KALLIKREIN | 2012 |
|
RU2607045C2 |
PROLYL HYDROXYLASE INHIBITORS AND APPLICATION METHODS THEREOF | 2007 |
|
RU2429226C9 |
THIOPHENYL AND PYRROLYL AZEPINES AS SEROTONIN 5HT RECEPTOR LIGANDS AND USE THEREOF | 2007 |
|
RU2434872C2 |
DERIVATIVES OF 8-METHOXY-[1,2,4]TRIAZOLO[1,5-a]PYRIDINE AND PHARMACEUTICAL PREPARATION BASED ON THEREOF | 2002 |
|
RU2297416C2 |
HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS | 2010 |
|
RU2615130C2 |
Authors
Dates
2011-05-20—Published
2006-09-20—Filed